283 related articles for article (PubMed ID: 9573548)
1. Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA.
Grossetête B; Launay P; Lehuen A; Jungers P; Bach JF; Monteiro RC
Kidney Int; 1998 May; 53(5):1321-35. PubMed ID: 9573548
[TBL] [Abstract][Full Text] [Related]
2. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-gamma.
Silvain C; Patry C; Launay P; Lehuen A; Monteiro RC
J Immunol; 1995 Aug; 155(3):1606-18. PubMed ID: 7636220
[TBL] [Abstract][Full Text] [Related]
4. Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients.
Grossetête B; Viard JP; Lehuen A; Bach JF; Monteiro RC
AIDS; 1995 Mar; 9(3):229-34. PubMed ID: 7755910
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of polymeric lambda-IgA binding to leukocytes in IgA nephropathy.
Lai KN; Chan LY; Tang SC; Tsang AW; Guo H; Tse KC; Yip T; Leung JC
J Am Soc Nephrol; 2002 Sep; 13(9):2309-19. PubMed ID: 12191975
[TBL] [Abstract][Full Text] [Related]
6. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
Novak J; Vu HL; Novak L; Julian BA; Mestecky J; Tomana M
Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
[TBL] [Abstract][Full Text] [Related]
7. Impaired expression of IgA Fc receptors (CD89) by blood phagocytic cells in ankylosing spondylitis.
Montenegro V; Chiamolera M; Launay P; Gonçalves CR; Monteiro RC
J Rheumatol; 2000 Feb; 27(2):411-7. PubMed ID: 10685807
[TBL] [Abstract][Full Text] [Related]
8. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
[TBL] [Abstract][Full Text] [Related]
9. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
10. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
11. IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells.
Toyabe S; Kuwano Y; Takeda K; Uchiyama M; Abo T
Clin Exp Immunol; 1997 Nov; 110(2):226-32. PubMed ID: 9367406
[TBL] [Abstract][Full Text] [Related]
12. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
14. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
[TBL] [Abstract][Full Text] [Related]
15. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
16. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
Lai KN; To WY; Li PK; Leung JC
Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
[TBL] [Abstract][Full Text] [Related]
17. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
Novak J; Tomana M; Matousovic K; Brown R; Hall S; Novak L; Julian BA; Wyatt RJ; Mestecky J
Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
[TBL] [Abstract][Full Text] [Related]
18. Glomerular Fc alphaR expression and disease activity in IgA nephropathy.
Kashem A; Endoh M; Yano N; Yamauchi F; Nomoto Y; Sakai H; Kurokawa K
Am J Kidney Dis; 1997 Sep; 30(3):389-96. PubMed ID: 9292568
[TBL] [Abstract][Full Text] [Related]
19. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic role of IgA receptors in IgA nephropathy.
Monteiro RC
Contrib Nephrol; 2007; 157():64-9. PubMed ID: 17495439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
